Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $111.4 million.

  • Cross Country Healthcare's Free Cash Flow rose 18242.99% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year decrease of 5382.01%. This contributed to the annual value of $111.4 million for FY2024, which is 5249.87% down from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Free Cash Flow is $111.4 million, which was down 5249.87% from $234.5 million recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's Free Cash Flow registered a high of $234.5 million during FY2023, and its lowest value of -$92.8 million during FY2021.
  • For the 5-year period, Cross Country Healthcare's Free Cash Flow averaged around $80.2 million, with its median value being $111.4 million (2024).
  • In the last 5 years, Cross Country Healthcare's Free Cash Flow soared by 76813.99% in 2020 and then crashed by 51076.63% in 2021.
  • Over the past 5 years, Cross Country Healthcare's Free Cash Flow (Annual) stood at $22.6 million in 2020, then crashed by 510.77% to -$92.8 million in 2021, then surged by 235.0% to $125.3 million in 2022, then surged by 87.22% to $234.5 million in 2023, then tumbled by 52.5% to $111.4 million in 2024.
  • Its Free Cash Flow was $111.4 million in FY2024, compared to $234.5 million in FY2023 and $125.3 million in FY2022.